Fundraising Fox

John-Paul Gallivan

Founder

Head of Development Co-founder at Coultreon

Edinburgh, Scotland, United Kingdom

FoundedCoultreon

Head of Development Co-founder at Coultreon

Intro paths

→

In turn, John-Paul can intro founders to Coultreon's investors below.

Coultreon's investors · 8

BAM ElevateChicago · since 2026Finchley Healthcare VenturesMontreal · since 2026ForbionNaarden · since 2026Longwood FundBoston · since 2026Luma GroupNew York · since 2026Novo HoldingsCopenhagen · $1.1M – $54M checks · since 2026Samsara BioCapitalPalo Alto · since 2026Sofinnova VenturesMenlo Park · $100K – $15M checks · since 2026

Co-founders at Coultreon

PRPierre Raboisson
Pierre RaboissonChief Executive Officer Chief Scientific Officer Co-founder
MDMarie De Vulder
Marie De VulderChief Legal Officer Co-founder
GPGuy Peeters
Guy PeetersChief Financial Officer Co-founder
FKFabrice Kolb
Fabrice KolbHead of Immunology Co-founder
PP
Pieter PeetersOperating & Technology Officer Co-founder
FGFrançois Gonzalvez
François GonzalvezCo-founder
SVSandrine Vendeville
Sandrine VendevilleCo-founder
JKJoost Kolkman
Joost KolkmanCo-founder

Experience

  1. Coultreon BiopharmaHead of Developmentcurrent2026 — present
  2. Onco3R TherapeuticsHead of Developmentcurrent2025 — present
  3. GalapagosProgram Leader Small Molecules and Antibodies2024 — 2025Edinburgh, Scotland, United Kingdom
  4. NuCana plcSenior Vice President Strategy and Lifecycle Management2024Edinburgh, Scotland, United Kingdom
  5. NuCana plcVice President, Strategy and Lifecycle Management2021 — 2024
  6. NuCana plcVice President, Clinical Development and Medical Affairs2019 — 2021Edinburgh, United Kingdom
  7. RocheGroup Lead, Medical Affairs- Breast and Gynae Cancers and Pan-Oncology Franchises2015 — 2019Basel
  8. RocheScientific Communications Leader, Breast Cancer, Global Medical Affairs2014 — 2015Basel Area, Switzerland
  9. Boehringer IngelheimAssociate International Project Leader- Oncology and Hematology2014Ingelheim, Germany
  10. Boehringer IngelheimMedical Advisor, Global Clinical Development and Medical Affairs- HCV2012 — 2014
  11. Boehringer IngelheimGlobal Publications Strategy Manager- HCV2011 — 2012
  12. Bristol-Myers SquibbMedical Education Manager (Hybrid Role with previous MSL position)2010 — 2011
  13. Bristol-Myers SquibbMedical Science Liaison2008 — 2010London, United Kingdom
  14. MediTech MediaAccount Manager2006 — 2008

Skills & more

Medical AffairsHematologyOncologyInfectious DiseasesMedical EducationClinical DevelopmentPharmaceutical IndustryMedical WritingBiochemistryMarket AccessMedicineClinical Trials
+4 moreBiotechnologyKOL DevelopmentVirologyLife Sciences

Languages English · German

From John-Paul's professional profile.

Frequently asked questions

Who is John-Paul Gallivan?
Head of Development Co-founder at Coultreon
Where does John-Paul Gallivan work?
John-Paul Gallivan is Head of Development Co-founder of Coultreon.
What companies did John-Paul Gallivan found?
John-Paul Gallivan founded Coultreon.
Where did John-Paul Gallivan go to school?
John-Paul Gallivan studied at Imperial College London (PhD, Virology); Imperial College London (M.Sc (Distinction), Virology); The University of Edinburgh (B.Sc (2.1), Medical Microbiology).

Same school

Also attended Imperial College London715

Deji SasegbonVP, Platform & Portfolio Operations at EchoVC PartnersMadison LenormandInvestor at DaphniLoubaba El AyoubiInvestor at NorthzoneGiovanni MariggiInvestor at MedicxiFrancois PrinslooInvestor at MedicxiBen PerryInvestor at Medicxi

+ 709 more

Also attended The University of Edinburgh349

Sofia DolfeInvestor at Index VenturesFreya Svedberg-KeatingInvestor at MedicxiKevin JohnsonInvestor at MedicxiPatrick NorrisGeneral Partner at Notion CapitalSarah MandersonLegal Director at Hoxton VenturesPolly BarnesInvestor at EQT Ventures

+ 343 more

Shared employers

Also worked at Coultreon Biopharma8

Maha KatabiGeneral Partner at Sofinnova VenturesPierre RaboissonChief Executive Officer Chief Scientific Officer Co-founder at CoultreonMarie De VulderChief Legal Officer Co-founder at CoultreonGuy PeetersChief Financial Officer Co-founder at CoultreonFabrice KolbHead of Immunology Co-founder at CoultreonFrançois GonzalvezCo-founder at Coultreon

+ 2 more

Also worked at Galapagos13

Marco PrunottoInvestor at MedicxiMichele MantoVenture Partner at XGEN VentureHelmuth van EsAdvisory Committee member at Curie CapitalRianne EllenbroekPrincipal at BioGeneration VenturesPaul StoffelsVice President at Johnson & Johnson Innovation – JJDCRonald BrusFounder and Chief Growth Officer at Leyden Labs

+ 7 more

Also worked at Roche147

Joe HorsmanInvestor at Madrona Venture GroupMarco PrunottoInvestor at MedicxiMike FitzgeraldInvestor at High AlphaUri LopatinInvestor at Khosla VenturesJan-Olivier FillolsSenior Managing Director at Marlin Equity PartnersCyndi ReseburgInvestor at Initialized Capital

+ 141 more

Also worked at Bristol-Myers Squibb88

Dan LynchInvestor at GV (Google Ventures)Scott BillerInvestor at GV (Google Ventures)Avantika DaingFounding Partner at Plum Alley InvestmentsJake BauerVenture Partner at ARCH Venture PartnersScott DonohueSenior Director, Market Access at Deerfield Management CompanyMellissa GraySenior Scientist, Protein Sciences at Deerfield Management Company

+ 82 more